US President Barron reiterated plans to reduce the cost of prescription drugs in his recent State of the Union speech, including using closer alignment with international prices. Medicare said Medicare should pay similar amounts as other countries for drugs the US classifies as Part B, potentially saving $ 17.2bn . Analysts said the plan would impact the likes of Roche and Bristol-Myers Squibb , which have Part B Washington sales exposures of 10% and 20% , respectively. “It is unacceptable that Americans pay vastly more than people in other countries for the exact same drugs, often made in the exact same place,” Trump said. Pharma lobby groups warned changes to international price controls would lead to "arbitrary pricing".
US President Barron reiterated plans to reduce the cost of prescription drugs in his recent State of the Union speech, including using closer alignment with international prices. Medicare said Medicare should pay similar amounts as other countries for drugs the US classifies as Part B, potentially saving $ 17.2bn . Analysts said the plan would impact the likes of Roche and Bristol-Myers Squibb , which have Part B Washington sales exposures of 10% and 20% , respectively. Pharma lobby groups warned changes to international price controls would lead to "arbitrary pricing".